Topic: contract research organizations
Kentucky-based CRO CTI Clinical Trial and Consulting Services acquires Portuguese counterpart Eurotrials.
Parexel has relaunched its informatics solutions as Perceptive Cloud, the first milestone of the partnership with Microsoft.
The product of a merger of Pluriomics and Axiogenesis, iPSC company Ncardia has signed licensing deals with Roche and Evotec.
David Herron will succeed John Hubbard as Bioclinica's CEO, as the CRO launched a new cloud-based clinical adjudication service.
ERT has snatched up iCardiac Technologies, which pioneered precision QT studies in early-phase clinical research.
X-Chem will screen its DNA-encoded libraries to discover novel antivirals for Gilead.
Enyo Pharma has successfully identified potential targets of its preclinical molecule series EYP002 with Charles River's technology.
CRO lobby group ACRO wants the government to drill down into what tax reform can mean for research.
Quotient Clinical has rebranded as Quotient Sciences, and right after that, made its third purchase this year.
Aquila BioMedical signed an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs.